Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000264428

Medchemexpress LLC BVT.13 | 756813-87-3 | 98.4% | 404.2 | C18H11Cl2N3O4 | 5 MG
SDP

Supplier:  Medchemexpress LLC HY1148535MG

Encompass_Preferred

BVT.13 is an orally active, selective peroxisome proliferator-activated receptor gamma (PPARγ) agonist used as a research compound. It displays a maximal efficacy similar to rosiglitazone and has demonstrated antidiabetic activity in ob/ob mice, making it useful for studies of PPARγ signaling, metabolic regulation, and preclinical efficacy testing.

  • Selective PPARγ agonist activity.
  • Oral bioactivity demonstrated in animal models.
  • Demonstrated antidiabetic efficacy in ob/ob mice.
  • High purity: 98.4% (HPLC).
  • Suitable for in vitro and in vivo research applications.
  • Molecular weight 404.2; formula C18H11Cl2N3O4.

Catalog No. 50-002-64428


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.